Pasithea Therapeutics Corp (KTTA)

Finanzdaten der Pasithea Therapeutics Corp-Aktie (KTTA)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	25.26%3.69	2.94	2.74	1.36	2.15
Research and Development	25.26%3.69	2.94	2.74	1.36	2.15
Operating Income/Loss	17.16%-5.71	-4.88	-10.26	-3.11	-3.81
Nonoperating Income/Loss	78.11%0.44	2.01	0.15	0.07	0.09
Income/Loss From Continuing Operations Before Tax	83.79%-5.27	-2.87	-10.11	-3.04	-3.72
	83.79%-5.27	-2.87	-10.11	-3.04	-3.72
Attributable To Parent	83.79%-5.27	-2.87	-10.11	-3.04	-3.72
Basic Average Shares	31.89%32.10	24.34	-	7.44	5.64
Diluted Average Shares	31.89%32.10	24.34	-	7.44	5.64
Basic Earnings Per Share	33.33%-0.16	-0.12	-	-0.41	-0.66
Diluted Earnings Per Share	33.33%-0.16	-0.12	-	-0.41	-0.66